CANSINO BIOLOGICS IN

6185
End-of-day quote. End-of-day quote  - 10/27
165.6HKD -2.87%
Prev.170.5000
Open171.8000
High174.0000
Low163.6000
Volume1 050 965
Latest news
7d ago
7d ago
10/15
10/13
Chart CANSINO BIOLOGICS INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance190271271
Spread/Res.-13%-39%-39%
Spread/Supp.4,1%16%31%
Support159142126
Financials
Sales 2020 275 M 40,9 M 40,9 M
Net income 2020 -6,87 M -1,02 M -1,02 M
Net cash 2020 2 901 M 432 M 432 M
P/E ratio 2020 -5 381x
Yield 2020 -
Capitalization 60 561 M 9 031 M 9 022 M
EV / Sales 2020 210x
EV / Sales 2021 89,4x
Nbr of Employees 429
Free-Float 37,1%
Company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
No events available
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 5
Average target price 157,99 CNY
Last Close Price 143,28 CNY
Spread / Highest target 51,7%
Spread / Average Target 10,3%
Spread / Lowest Target -67,8%